Your browser doesn't support javascript.
loading
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study‡.
Conte, P; Frassoldati, A; Bisagni, G; Brandes, A A; Donadio, M; Garrone, O; Piacentini, F; Cavanna, L; Giotta, F; Aieta, M; Gebbia, V; Molino, A; Musolino, A; Ferro, A; Maltoni, R; Danese, S; Zamagni, C; Rimanti, A; Cagossi, K; Russo, A; Pronzato, P; Giovanardi, F; Moretti, G; Lombardo, L; Schirone, A; Beano, A; Amaducci, L; Bajardi, E A; Vicini, R; Balduzzi, S; D'Amico, R; Guarneri, V.
Afiliación
  • Conte P; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Medical Oncology 2, Istituto Oncologico Veneto (IOV), IRCCS, Padova, Italy. Electronic address: pierfranco.conte@unipd.it.
  • Frassoldati A; Clinical Oncology, Department of Morphology, Surgery and Experimental Medicine, S Anna University Hospital, Ferrara, Italy.
  • Bisagni G; Department of Oncology and Advanced Technologies, Oncology Unit, IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia, Italy.
  • Brandes AA; Medical Oncology, Azienda Unità Sanitaria Locale di Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy.
  • Donadio M; Department of Medical Oncology 1, Città della Salute e della Scienza Hospital, Turin, Italy.
  • Garrone O; Medical Oncology, A.O. S. Croce and Carle Teaching Hospital, Cuneo, Italy.
  • Piacentini F; Division of Medical Oncology, Department of Medical and Surgical Sciences for Children & Adults, University Hospital of Modena, Modena, Italy; Azienda Ospedaliero-Universitaria di Modena, Modena, Italy.
  • Cavanna L; Department of Oncology-Hematology, G. da Saliceto Hospital, Piacenza, Italy.
  • Giotta F; Division of Medical Oncology, IRCCS, Giovanni Paolo II Hospital, Bari, Italy.
  • Aieta M; Division of Medical Oncology, IRCCS-CROB, Referral Cancer Center of Basilicata, Rionero Vulture (PZ), Italy.
  • Gebbia V; Medical Oncology, Casa di Cura La Maddalena, University of Palermo, Palermo, Italy.
  • Molino A; Oncology Unit, Verona University Hospital, Verona, Italy.
  • Musolino A; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Ferro A; Medical Oncology, Santa Chiara Hospital, Trento, Italy.
  • Maltoni R; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRST, IRCCS, Meldola, Italy.
  • Danese S; Department of Gynecology and Obstetrics, Ospedale S. Anna, Turin, Italy.
  • Zamagni C; Policlinico S.Orsola-Malpighi, SSD Oncologia Medica Addarii, Bologna, Italy.
  • Rimanti A; Medical Oncology, Azienda Ospedaliera Carlo Poma, Mantova, Italy.
  • Cagossi K; Division of Medical Oncology, "B.Ramazzini" Hospital, Carpi, Italy.
  • Russo A; Section of Medical Oncology, Department of Surgical and Oncological Sciences, University of Palermo, Palermo, Italy.
  • Pronzato P; Department of Medical Oncology, U.O. Oncologia Medica 2, IRCCS AOU San Martino-IST, Genova, Italy.
  • Giovanardi F; Department of Oncology and Advanced Technologies, Oncology Unit, IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia, Italy.
  • Moretti G; Department of Oncology and Advanced Technologies, Oncology Unit, IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia, Italy.
  • Lombardo L; Medical Oncology, Azienda Unità Sanitaria Locale di Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy.
  • Schirone A; Clinical Oncology, Department of Morphology, Surgery and Experimental Medicine, S Anna University Hospital, Ferrara, Italy.
  • Beano A; Department of Medical Oncology 1, Città della Salute e della Scienza Hospital, Turin, Italy.
  • Amaducci L; Medical Oncology Unit, Ospedale degli Infermi Faenza, Faenza, Italy.
  • Bajardi EA; Medical Oncology, Casa di Cura La Maddalena, University of Palermo, Palermo, Italy.
  • Vicini R; Department of Diagnostic and Clinical Medicine and Public Health, Statistics Unit, University Hospital of Modena and Reggio Emilia, Modena, Italy.
  • Balduzzi S; Department of Diagnostic and Clinical Medicine and Public Health, Statistics Unit, University Hospital of Modena and Reggio Emilia, Modena, Italy.
  • D'Amico R; Azienda Ospedaliero-Universitaria di Modena, Modena, Italy; Department of Diagnostic and Clinical Medicine and Public Health, Statistics Unit, University Hospital of Modena and Reggio Emilia, Modena, Italy.
  • Guarneri V; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Medical Oncology 2, Istituto Oncologico Veneto (IOV), IRCCS, Padova, Italy.
Ann Oncol ; 29(12): 2328-2333, 2018 12 01.
Article en En | MEDLINE | ID: mdl-30219886
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Cardiotoxicidad / Trastuzumab / Antineoplásicos Inmunológicos Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Cardiotoxicidad / Trastuzumab / Antineoplásicos Inmunológicos Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article